Science & Enterprise subscription

Follow us on Twitter

  • Regulatory review of a drug to prevent allergic reactions to peanuts appears to be delayed by the shutdown of some… https://t.co/mSAKgI1Dry
    about 6 hours ago
  • New post on Science and Enterprise: Shutdown Delays FDA Peanut Allergy Drug Review https://t.co/vvspUdBnOM #Science #Business
    about 6 hours ago
  • Customized implants, produced on a 3-D printer and seeded with stem cells, are shown in tests with lab animals to… https://t.co/hc4xTlmSQq
    about 10 hours ago
  • New post on Science and Enterprise: 3-D Printed Implants Treat Spinal Cord Injury https://t.co/2ZiVpVvMIz #Science #Business
    about 10 hours ago
  • New contributed post on Science and Enterprise: https://t.co/z76z7xMWD3 Lighten The Load: Making Business Ownership Less Complex
    about 16 hours ago

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn
INSTAGRAM

Duchenne Stem Cell Trial Halted

Stop signs graphic

A clinical trial testing stem cell treatments for symptoms of Duchenne muscular dystrophy is on hold after a patient reported a severe reaction. . . . → Read More: Duchenne Stem Cell Trial Halted

Toxic Neuro Protein Clearance Company Formed

Nerve cells in brain

A new enterprise is being formed to develop a device that clears from the nervous system toxic proteins associated with chronic and debilitating neurological disorders. . . . → Read More: Toxic Neuro Protein Clearance Company Formed

FDA Clears Inhaled Parkinson’s Drug

Brain circuits

A drug administered as an inhaled powder to supplement a common treatment for Parkinson’s disease received approval for marketing from the Food and Drug Administration. . . . → Read More: FDA Clears Inhaled Parkinson’s Drug

Eye Drops Reverse Infected Eye Scarring

Eyes looking at laptop

Eye drops containing a therapeutic protein and applied as a gel, are shown in lab mice to remove scar tissue from the surface of infected or damaged corneas. . . . → Read More: Eye Drops Reverse Infected Eye Scarring

Nanoscale Bacteria Particles Deliver Cancer Drugs

Salmonella typhimurium

An engineering lab developed techniques for delivering cancer drugs into tumors in lab cultures and mice with nanoscale polymer particles, aided by a strain of salmonella bacteria. . . . → Read More: Nanoscale Bacteria Particles Deliver Cancer Drugs

Drug Discovery Start-Up Gains $400M Financing

Glasses, computer screens

A 2 year-old company using computational techniques to find protein-targeting drugs raised $400 million in new financing, led by the venture funding arm of Softbank. . . . → Read More: Drug Discovery Start-Up Gains $400M Financing

Nanotech Gene Therapy Company Raises $8.5M in Seed Funds

Editing DNA

A start-up company developing nanoscale particles to deliver gene-editing enzymes, including those for Crispr, is raising $8.5 million in its seed funding round. . . . → Read More: Nanotech Gene Therapy Company Raises $8.5M in Seed Funds

RNA Biotech Raises $604M in IPO

NASDAQ share price display

Moderna Therapeutics, a biotechnology enterprise developing therapies with synthetic RNA, issued its initial public stock offering, or IPO, on Thursday, raising more than $604 million. . . . → Read More: RNA Biotech Raises $604M in IPO

Report – 289 Cell and Gene Therapies in Development

Human T-cell

A report by a pharmaceutical industry organization says nearly 300 new therapies that transfer live cells or genes as treatments for disease are in clinical trials or being reviewed by Food and Drug Administration. . . . → Read More: Report – 289 Cell and Gene Therapies in Development

Trial Results Show Gene Transfers Reverse Sickle Cell Disease

Gene therapy lab

Results from the first 2 participants in a clinical trial show transferring healthy genes to patients with sickle cell disease reverses symptoms of the disease that continues for up to 1 year. . . . → Read More: Trial Results Show Gene Transfers Reverse Sickle Cell Disease